Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.57 |
| ▸ | IL23R | Q5VWK5 | 6/20 | 0.51 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.49 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.49 |
| ▸ | NPY1R | P25929 | 2/20 | 0.48 |
| ▸ | NPY2R | P49146 | 2/20 | 0.48 |
| ▸ | NPY4R | P50391 | 2/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30312694 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312720 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312704 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312692 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312683 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312707 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312660 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312706 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312724 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 | |
| SCHEMBL30312729 | 0.95 | QRFPR (0.52) | TFPIIL23RQRFPROPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066254-A | Human anti-inflammatory peptides for inhalation treatment of inflammatory lung diseases | 阿德维塔生命科学有限责任公司 | 2022-09-16 | — | — | CN | disclosed |